Psoriatic arthritis: improvement in outcomes but persistent sex difference – 5-year follow-up study of a Norwegian outpatient clinic population

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs

(2022) Alen Brkic et al.   BMC HEALTH SERVICES RESEARCH

Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents

(2022) AM Kerola et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials

(2022) Lihi Eder et al.   Rheumatology and Therapy

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

(2022) Laura C. Coates et al.   Nature Reviews Rheumatology

Sex-Specific Differences in Patients with Psoriatic Arthritis: A Systematic Review

(2022) Laura C. Coates et al.   JOURNAL OF RHEUMATOLOGY

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis

(2022) Alen Brkic et al.   Rheumatology and Therapy

Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies

(2022) Emilce E. Schneeberger et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The burden of psoriatic arthritis in the biological era: data from the Belgian Epidemiological Psoriatic Arthritis Study (BEPAS)

(2021) Kurt de Vlam et al.   RHEUMATOLOGY

Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: A multi-center study

(2021) Mehmet Tuncay Duruöz et al.   JOINT BONE SPINE

Psoriatic arthritis

(2021) Oliver FitzGerald et al.   Nature Reviews Disease Primers

Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists

(2021) Halise Hande Gezer et al.   JOINT BONE SPINE

Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis

(2020) Benjamin Hagège et al.   RHEUMATOLOGY

REMISSION IN PSORIATIC ARTHRITIS: DEFINITION AND PREDICTORS

(2020) Samar Alharbi et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

(2020) Iain B McInnes et al.   LANCET

Comparison of Remission and Low Disease activity states with DAPSA, MDA and VLDA in a Clinical Trial Setting in Psoriatic Arthritis Patients: 2-year Results from the FUTURE 2 Study

(2020) Laura C Coates et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Meta-Analysis

(2019) Ahmed Mourad et al.   JOURNAL OF RHEUMATOLOGY

Gender differences in biologic treatment outcomes—a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers

(2018) Pil Højgaard et al.   RHEUMATOLOGY

Considerations for the definition of remission criteria in psoriatic arthritis

(2018) Philip J. Mease et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis

(2018) Philip D H Hamann et al.   RHEUMATOLOGY

Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population

(2017) Brigitte Michelsen et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis

(2017) Dongze Wu et al.   RHEUMATOLOGY

Sex Differences in Pain

(2016) Robert E. Sorge et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

(2015) Monika M Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

(2015) Glenn Haugeberg et al.   ARTHRITIS RESEARCH & THERAPY

Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

(2014) Fausto Salaffi et al.   Biomed Research International

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men

(2013) David Hägg et al.   PLoS One

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

(2011) D. T. Felson et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

(2010) Laura C. Coates et al.   ARTHRITIS CARE & RESEARCH

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

(2008) G Wells et al.   ANNALS OF THE RHEUMATIC DISEASES

Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis

(2008) Paul J. Healy et al.   ARTHRITIS AND RHEUMATISM